A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
Condition: Malignant Solid Tumor Interventions: Drug: HDM201; Drug: Ribociclib; Drug: Cabozantinib Sponsor: Centre Leon Berard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials